We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > INO-4800

News List

Inovio commences Phase I trial of DNA vaccine for Covid-19 pharmaceutical-technology
April 08, 2020
Inovio Pharmaceuticals has received approval from the US Food and Drug Administration (FDA) for the investigational new drug (IND) application of its DNA vaccine candidate INO-4800 against Covid-19.
Inovio secures funds for delivery device of Covid-19 vaccine pharmaceutical-technology
March 16, 2020
Inovio Pharmaceuticals has received a $5m grant from the Bill & Melinda Gates Foundation to support the testing and scale-up of a smart delivery device for Covid-19 vaccine, INO-4800.
Inovio Pharmaceuticals set to trial Covid-19 vaccine in April pharmaceutical-technology
March 05, 2020
Inovio Pharmaceuticals has expedited its timeline for the development of a Covid-19 vaccine candidate, INO-4800, with human clinical trials scheduled for April.

Previous page 1 2 3 4 Next page